Abviva, Inc.: New Case of Mad Cow Disease Detected in North America  
7/1/2008 1:14:10 PM

LOS ANGELES--(BUSINESS WIRE)--Abviva, Inc. (OTCBB: AVVA) today announced that BioBDC International (BioBDC), Abviva’s exclusive sales agent for Mad Cow diagnostic tests produced by Abviva’s subsidiary company Prion Developmental Laboratories, Inc. (PDL), reported the Canadian Food Inspection Agency confirmed a new case of mad cow disease, bovine spongiform encephalopathy (BSE), was discovered in western Canada, increasing consumer’s concerns over beef safety.